Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 92 Issue 3

TABLE OF CONTENTS Volume 92, Issue 3 (September 2012) In this issue In This Issue Editorial News & Views Perspectives Discovery State of the Art Review Research Development Regulation & Use Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Now accepting submissions Open Access - Peer Review - Renowned International Editorial Board A new online open access journal in the pharmacometrics and systems pharmacology space.   In This Issue Top In This Issue Clin Pharmacol Ther 2012 92: 265; 10.1038/clpt.2012.134 Full Text Editorial Top Gastrohepatology: Tools, Targets, and Trajectories L P James and J Senior Clin Pharmacol Ther 2012 92: 267-271; 10.1038/clpt.2012.123 Abstract | Full Text News & Views Top Highlights Clin Pharmacol Ther 2012 92: 272-273; 10.1038/clpt.2012.135 Full Text ASCPT News Clin Pharmacol Ther 2012 92: 274-278; 10.1038/clpt.2012.132 Full Text BOOKS Polypharmacology in Drug Discovery Reviewed by  F Innocenti Clin Pharmacol Ther 2012 92: 279-280; 10.1038/clpt.2012.129 Full Text Perspectives Top COMMENTARIES Clinical Pharmacology Considerations in Development of Gastrohepatology Products S-C Lee, S Apparaju, I Kim, K Estes, D Jappar and E D Bashaw Clin Pharmacol Ther 2012 92: 281-283; 10.1038/clpt.2012.121 Abstract | Full Text Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During Drug Development D R Mould Clin Pharmacol Ther 2012 92: 283-286; 10.1038/clpt.2012.122 Abstract | Full Text Discovery Top CFTR Inhibitors for Treating Diarrheal Disease J R Thiagarajah and A S Verkman Clin Pharmacol Ther 2012 92: 287-290; advance online publication, August 1, 2012; 10.1038/clpt.2012.114 Abstract | Full Text Serum microRNA Biomarkers for Drug-Induced Liver Injury P J Starkey Lewis, M Merz, P Couttet, O Grenet, J Dear, D J Antoine, C Goldring, B K Park and J G Moggs Clin Pharmacol Ther 2012 92: 291-293; advance online publication, July 25, 2012; 10.1038/clpt.2012.101 Abstract | Full Text State of the Art Top New Pharmacotherapy for Hepatitis C D N Assis and J K Lim Clin Pharmacol Ther 2012 92: 294-305; advance online publication, August 1, 2012; 10.1038/clpt.2012.103 Abstract | Full Text Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases D A Katzka, E V Loftus, Jr and M Camilleri Clin Pharmacol Ther 2012 92: 306-320; advance online publication, July 25, 2012; 10.1038/clpt.2012.77 Abstract | Full Text Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy C F Rose Clin Pharmacol Ther 2012 92: 321-331; advance online publication, August 8, 2012; 10.1038/clpt.2012.112 Abstract | Full Text Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future J R Senior Clin Pharmacol Ther 2012 92: 332-339; advance online publication, August 8, 2012; 10.1038/clpt.2012.108 Abstract | Full Text Review Top Nrf2: A Potential Target for New Therapeutics in Liver Disease A M Bataille and J E Manautou Clin Pharmacol Ther 2012 92: 340-348; advance online publication, August 8, 2012; 10.1038/clpt.2012.110 Abstract | Full Text International Vision and Strategy for Drug Regulatory Authority: The PMDA's International Vision Toshiyoshi Tominaga, Yuki Ando and Tatsuya Kondo Clin Pharmacol Ther 2012 92: 349-351; advance online publication, August 8, 2012; 10.1038/clpt.2012.90 Abstract | Full Text Research Top ARTICLES Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development I Demin, B Hamrén, O Luttringer, G Pillai and T Jung Clin Pharmacol Ther 2012 92: 352-359; advance online publication, July 4, 2012; 10.1038/clpt.2012.69 Abstract | Full Text Concordance of DMET Plus Genotyping Results With Those of Orthogonal Genotyping Methods C A Fernandez, C Smith, W Yang, R Lorier, K R Crews, N Kornegay, J K Hicks, C F Stewart, J D Kawedia, L B Ramsey, C Liu, W E Evans, M V Relling and U Broeckel Clin Pharmacol Ther 2012 92: 360-365; advance online publication, August 8, 2012; 10.1038/clpt.2012.95 Abstract | Full Text In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients H de Jonge, H de Loor, K Verbeke, Y Vanrenterghem and D R Kuypers Clin Pharmacol Ther 2012 92: 366-375; advance online publication, August 8, 2012; 10.1038/clpt.2012.109 Abstract | Full Text Development Top Predictive Genetic Testing for Drug-Induced Liver Injury: Considerations of Clinical Utility A Alfirevic and M Pirmohamed Clin Pharmacol Ther 2012 92: 376-380; advance online publication, August 1, 2012; 10.1038/clpt.2012.107 Abstract | Full Text Molecular Targets for the Treatment of Fibrosing Cholangiopathies L J Maillette de Buy Wenniger, R P Oude Elferink and U Beuers Clin Pharmacol Ther 2012 92: 381-387; advance online publication, August 1, 2012; 10.1038/clpt.2012.111 Abstract | Full Text Regulation & Use Top PRACTICE Failure of Proton Pump Inhibitors to Treat GERD in Neonates and Infants: A Question of Drug, Diagnosis, or Design V Shakhnovich, R M Ward and G L Kearns Clin Pharmacol Ther 2012 92: 388-392; advance online publication, July 18, 2012; 10.1038/clpt.2012.86 Full Text Construction of an Open-Access QT Database for Detecting the Proarrhythmia Potential of Marketed Drugs: ECG-ViEW M Y Park, D Yoon, N K Choi, J Lee, K Lee, H S Lim, B J Park, J H Kim and R W Park Clin Pharmacol Ther 2012 92: 393-396; advance online publication, July 25, 2012; 10.1038/clpt.2012.93 Abstract | Full Text Corrigendum Top Corrigendum: Impact of the β1-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients Clin Pharmacol Ther 2012 92: 397; 10.1038/clpt.2012.98 Full Text Advertisement Ensure your access If you are unable to access the articles in thisalert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeProdRequest?id=clpt   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.